Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMARCO INCCMRO · Entity 173122 | Director | October 27, 2016 | October 31, 2016 |
| Insight Molecular Diagnostics Inc.IMDX · Entity 6631 | Director | July 01, 2026 | July 07, 2026 |
| STAAR SURGICAL COSTAA · Entity 4851 | Director | June 18, 2026 | June 22, 2026 |
| Veradigm Inc.MDRX · Entity 13670 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMARCO INC
Report date October 27, 2016 · Filed October 31, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Right to buySEC Table II · derivative / convertible security · Conversion / exercise price $0.14 · Expires 2025-06-17 | Direct | 50,000 |
Reported balance
After 2016-10-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-27 · Grant · Acquired 24,048 · Balance 50,000 F1: On June 17, 2015, the Reporting Person received 25,952 out of a total of 50,000 board approved options, as there were insufficient shares then available under the Issuer's 2011 Equity Incentive Plan and the remaining 24,048 options were granted subject to an increase in shares under the 2011 Equity Plan. As an increase in shares under the 2011 Equity Plan was recently approved at the Company's 2016 Annual Shareholders Meeting, this grant represents the balance of the June 17, 2015 award with the same vesting and expiration dates as the original 25,952 option grant on June 17, 2015. |
| Right to buySEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2026-10-27 | Direct | 50,000 |
Reported balance
After 2016-10-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-27 · Grant · Acquired 50,000 · Balance 50,000 F2: The Reporting Person received a grant of stock options pursuant to the Issuer's 2011 Equity Incentive Plan. The option shall vest in full on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 17, 2015, the Reporting Person received 25,952 out of a total of 50,000 board approved options, as there were insufficient shares then available under the Issuer's 2011 Equity Incentive Plan and the remaining 24,048 options were granted subject to an increase in shares under the 2011 Equity Plan. As an increase in shares under the 2011 Equity Plan was recently approved at the Company's 2016 Annual Shareholders Meeting, this grant represents the balance of the June 17, 2015 award with the same vesting and expiration dates as the original 25,952 option grant on June 17, 2015.
F2: The Reporting Person received a grant of stock options pursuant to the Issuer's 2011 Equity Incentive Plan. The option shall vest in full on the one-year anniversary of the grant date.
Insight Molecular Diagnostics Inc.
Report date July 01, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, no par valueSEC Table I · non-derivative | Direct | 55,807 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Tax withholding · Disposed 7,700 · Balance 55,807 F1: The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
STAAR SURGICAL CO
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,158 |
Reported balance
After 2026-06-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-18 · Exercise / conversion · Acquired 10,683 · Balance 11,158 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Exercise / conversion · Disposed 10,683 · Balance 0 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,182 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Grant · Acquired 6,182 · Balance 6,182 F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.
F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
Veradigm Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,131 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 42,507 · Balance 99,131 F1: Award of Restricted Stock Units granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026 (the "Grant Date"). The grant vests 100% on the first anniversary of the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of Restricted Stock Units granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026 (the "Grant Date"). The grant vests 100% on the first anniversary of the Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 7, 2026 00:40 UTC | Insight Molecular Diagnostics Inc. IMDX · Entity 6631 | Tax withholdingCommon Stock, no par value | 7,700 | $5.69 | $43,813.00 |
DisclosureSEC source: 0001493152-26-032235 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,807 F1 · security: The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 6,182 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001249935-26-000004 · ownership.xml · derivative · entry 3 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,182 Underlying: Common Stock · 6,182 shares Expires not disclosed F2 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F2 · derivative.exercise_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F2 · derivative.expiration_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 10,683 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001249935-26-000004 · ownership.xml · derivative · entry 2 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. F1 · derivative.exercise_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. F1 · derivative.expiration_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001249935-26-000004 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 22:22 UTC | Insight Molecular Diagnostics Inc. IMDX · Entity 6631 | GrantCommon Stock, no par value | 26,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-028755 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,507 F1 · security: The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 42,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-255558 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,131 F1 · kind: Award of Restricted Stock Units granted under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan on June 1, 2026 (the "Grant Date"). The grant vests 100% on the first anniversary of the Grant Date. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 20:05 UTC | Insight Molecular Diagnostics Inc. IMDX · Entity 6631 | GrantCommon Stock, no par value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-017796 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,564 F1 · security: The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:23 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 10,683 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088595 · ownership.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,683 Underlying: Common Stock · 10,683 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders. F2 · derivative.expiration_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 23:45 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 46,512 | $4.30 | $200,001.60 |
DisclosureSEC source: 0000950170-25-081245 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,624 F1 · kind: Award of Restricted Stock Units granted under the Veradigm, Inc. Amended and Restated 2024 Stock Incentive Plan on June 2, 2025 (the "Grant Date"). The grant vests 100% on the first anniversary of the Grant Date. Read SEC document |
| May 12, 2025 Filed May 13, 2025 22:04 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 2,440 | $0.00 Strike: $20.27 | $0.00 |
DisclosureSEC source: 0000950170-25-070617 · ownership.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,440 Underlying: Common Stock · 2,440 shares Expires 2035-05-11 F1 · security: Reflects options to purchase common stock granted on May 12, 2025, pursuant to the Corporation's standard non-employee director equity compensation program, pro-rated for the remaining portion of the 2024-2025 term. This award vests in full on June 18, 2025, the date of the Corporation's 2025 Annual Meeting of Shareholders. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 00:44 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 10,112 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-045626 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,112 F1 · kind: Award of Restricted Stock Units granted under the Veradigm, Inc. 2024 Veradigm Stock Incentive Plan on March 24, 2025. The award vests 100% on May 31, 2025 Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 01:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | GrantOption to Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001493152-24-026272 · ownership.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-07-01 F1 · derivative.exercise_date: Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. Read SEC document |
| June 23, 2023 Filed Jun 28, 2023 01:30 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | GrantOption to Purchase Common Stock · Derivative | 112,500 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001493152-23-022666 · ownership.xml · derivative · entry 2 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2033-06-23 F2 · derivative.exercise_date: Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. Read SEC document |
| June 23, 2023 Filed Jun 28, 2023 01:30 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | GrantCommon Stock, no par value | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-022666 · ownership.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,270 F1 · security: The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 9,921 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · derivative · entry 10 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,921 shares Expires 2027-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · derivative · entry 9 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $9.31 | $0.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · derivative · entry 8 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 9,921 | $145.54 | $1,443,902.34 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 6 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $153.68, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 9,921 | $9.60 | $95,241.60 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 5 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 10,000 | $145.56 | $1,455,600.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 4 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.98 to $153.68, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,000 | $8.35 | $83,500.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 3 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 10,000 | $145.57 | $1,455,700.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 2 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.96 to $153.68, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,000 | $9.31 | $93,100.00 |
DisclosureSEC source: 0001209191-21-051095 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 21:56 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043363 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The restrictions on the 807 restricted shares of common stock lapse on the earlier of June 24, 2022 or the Corporation's 2022 Annual Shareholders Meeting, subject to Mr. Silverman's continued service through that date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:40 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 23,996 | $104.78 | $2,514,300.88 |
DisclosureSEC source: 0001209191-21-016896 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.57 to $106.39, inclusive. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 21:24 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044768 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,850 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:23 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 4,268 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0001209191-19-038818 · doc4.xml · derivative · entry 3 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 Underlying: Common Stock · 4,268 shares Expires 2029-06-19 F3 · derivative.exercise_date: These stock options vest in full on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Silverman's continued service through the vesting date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:23 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 2,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038818 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,733 F1 · shares: The restrictions on the 2,127 restricted shares of common stock lapse on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Silverman's continued service through that date. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 20:42 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 7,155 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-18-038342 · doc4.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,155 Underlying: Common Stock · 7,155 shares Expires 2028-06-13 F1 · security: These stock options vest in full on the earlier of June 14, 2019 or the Corporation's 2019 Annual Meeting, subject to Mr. Silverman's continued service through the vesting date. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:11 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 1,206 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-18-020638 · doc4.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,206 Underlying: Common Stock · 1,206 shares Expires 2028-03-14 F1 · security: These stock options vest in full on the earlier of June 14, 2018 or the Corporation's 2018 Annual Meeting, subject to Mr. Silverman's continued service through the vesting date. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:12 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 9,921 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001209191-17-040112 · doc4.xml · derivative · entry 3 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,921 Underlying: Common Stock · 9,921 shares Expires 2027-06-12 F2 · derivative.exercise_date: These 9,921 stock options vest in full on the earlier of June 13, 2018 or the Corporation's 2018 Annual Meeting, subject to Mr. Silverman's continued service through the vesting date. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:12 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040112 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 F1 · balance_after: The restrictions on the 5208 restricted shares of common stock lapse on the earlier of June 13, 2018 or the Corporation's 2018 Annual Meeting, subject to Mr. Silverman's continued service through that date. Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 18:58 UTC | COMARCO INC CMRO · Entity 173122 | GrantRight to buy · Derivative | 50,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001437749-16-040679 · rdgdoc.xml · derivative · entry 2 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-10-27 F2 · security: The Reporting Person received a grant of stock options pursuant to the Issuer's 2011 Equity Incentive Plan. The option shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 18:58 UTC | COMARCO INC CMRO · Entity 173122 | GrantRight to buy · Derivative | 24,048 | $0.00 Strike: $0.14 | $0.00 |
DisclosureSEC source: 0001437749-16-040679 · rdgdoc.xml · derivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 24,048 shares Expires 2025-06-17 F1 · security: On June 17, 2015, the Reporting Person received 25,952 out of a total of 50,000 board approved options, as there were insufficient shares then available under the Issuer's 2011 Equity Incentive Plan and the remaining 24,048 options were granted subject to an increase in shares under the 2011 Equity Plan. As an increase in shares under the 2011 Equity Plan was recently approved at the Company's 2016 Annual Shareholders Meeting, this grant represents the balance of the June 17, 2015 award with the same vesting and expiration dates as the original 25,952 option grant on June 17, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.